The Close: S&P 500 Stumbles as Moderna Sinks on Report Questioning Trial Results
Major averages fell to session lows in the wake of a report from STAT News that questioned the validity of the results of Moderna’s vaccine trial, which the company had announced Monday. Moderna shares plunged about 10% after the report.